市場調查報告書
商品編碼
1540896
2024-2032 年按技術、動物類型、感染類型、最終用戶和地區分類的獸醫傳染病診斷市場報告Veterinary Infectious Disease Diagnostics Market Report by Technology, Animal Type, Infection Type, End User, and Region 2024-2032 |
2023年,全球IMARC Group傳染病診斷市場規模達20億美元。寵物和牲畜疾病盛行率的增加、寵物主人意識的提高、技術的進步、準確診斷的需要、先進工具的採用、寵物健康問題的加劇、獸醫基礎設施的擴大、政府預防人畜共患疾病的舉措以及研究經費的增加都是因素推動市場成長。
主要市場促進因素:在全球範圍內,人畜共通傳染病的盛行率不斷上升,大大增加了對先進診斷解決方案的需求,為市場創造了積極的前景。此外,政府對動物保健的措施和資金的增加正在推動獸醫傳染病診斷市場的成長。此外,畜牧業的擴張以及主要參與者不斷升級的研發(R&D)活動舉措正在推動市場成長。此外,照護端 (POC) 診斷的使用不斷增加、獸醫護理中遠距醫療的使用不斷成長,以及消費者對動物福利和品質標準的認知不斷提高,這些都進一步推動了獸醫傳染病診斷的需求。
主要市場趨勢:由於分子診斷具有卓越的敏感性和特異性,人們對分子診斷的偏好發生了轉變,這是主要市場趨勢之一。此外,由於可以現場操作,用於診斷的成簇規則間隔短回文重複序列(CRISPR)的大量使用是促進市場成長的另一個因素。此外,人工智慧(AI)和機器學習(ML)的不斷融合,特別是在診斷工具中,以產生更準確的結果,正在培育積極的獸醫傳染病診斷市場前景。與此一致的是,對伴侶動物的需求不斷增加,以及逐漸轉向同時檢測多種病原體的多重診斷檢測,正在推動市場的成長。此外,獸醫實踐和診斷實驗室之間的合作以及對即時(POC)診斷解決方案不斷成長的需求正在推動市場向前發展。
地理趨勢:根據獸醫傳染病診斷市場預測,北美由於先進的醫療基礎設施、寵物擁有量的增加以及動物健康投資的迅速成長而引領市場。此外,主要參與者對研發(R&D)的日益關注以及有利的政府政策正在支持區域市場的成長。由於嚴格的動物衛生法規和許多主要市場參與者的存在,歐洲在市場上佔有相當大的佔有率。此外,在亞太地區,人們對動物健康意識的不斷增強、傳染病診斷的便利性以及政府對動物健康的資助不斷增加,正在加速市場的成長。
競爭格局:獸醫傳染病診斷行業的一些主要市場參與者包括 Abbott Laboratories、Biomerieux SA、Creative Diagnostics、HESKA Corporation、Innovative Diagnostics、IDEXX Laboratories Inc.、Neogen Corporation、Qiagen NV、Randox Laboratories Ltd、Thermo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、維克等。
挑戰與機會:根據獸醫傳染病診斷市場報告,診斷工具的成本不斷上升是阻礙市場成長的主要因素之一。此外,監管障礙和複雜的核准流程給市場參與者帶來了各種挑戰,這是限制市場成長的另一個因素。然而,市場也提供了各種機會,例如動物傳染病的日益普及和寵物飼養量的增加正在建立對先進診斷的巨大需求。此外,技術的快速發展,包括方便易用的診斷設備的出現以及對獸醫健康和福利的日益關注,都是大大推動獸醫傳染病診斷市場收入的因素。
寵物和牲畜傳染病的盛行率不斷上升
寵物和牲畜傳染病的流行正在加速市場的成長。例如,貓白血病病毒 (FeLV) 是貓最常見的傳染病之一,影響美國和加拿大 2-3% 的貓科動物。寵物和人類之間的互動激增進一步放大了這種風險,從而進一步增加了疾病傳播的機會。此外,快速的城市化、畜牧業實踐的變化以及確診患者數量的增加正在支持市場的成長。推動獸醫傳染病診斷市場價值的另一個因素是對準確及時診斷的需求不斷成長,這有助於有效控制和遏制這些疾病。
提高寵物主人的意識
寵物主人對早期疾病檢測重要性的認知不斷提高是推動市場成長的關鍵因素。隨著寵物被視為不可分割的家庭成員,主人越來越重視它們的健康和福祉。這種意識的提高導致對定期健康檢查、預防措施和早期診斷測試的需求不斷成長。此外,先進診斷工具和技術的出現使寵物主人更容易獲得高品質的獸醫護理,進一步推動了對傳染病診斷的需求。
技術進步
根據市場概況,由於技術的快速進步,獸醫傳染病診斷的需求量很大。診斷的改進大大提高了結果的效率和準確性,這進一步推動了市場的成長。此外,旨在改善動物傳染病檢測和識別的分子診斷技術(例如聚合酶鏈反應(PCR))的引入也促進了市場成長。除此之外,自動化分析儀和遠距醫療平台等數位健康工具的結合簡化了診斷過程,這進一步支持了市場成長。
IMARC Group提供了每個細分市場的主要趨勢分析,以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據技術、動物類型、感染類型和最終用戶對市場進行了分類。
免疫診斷
分子診斷
其他
免疫診斷佔大部分市場佔有率
該報告基於該技術對市場進行了詳細的細分和分析。這包括免疫診斷、分子診斷等。根據該報告,免疫診斷佔最大的部分。
根據獸醫傳染病診斷市場研究報告,由於對準確疾病檢測的需求不斷增加,免疫診斷領域佔據最大的市場佔有率。免疫診斷測試,包括酵素連結免疫吸附測定 (ELISA) 和免疫螢光測定 (IFA),對於特異性檢測與傳染病相關的抗體或抗原的能力至關重要。這種精確度對於早期識別病原體和診斷疾病至關重要,這對於有效治療和疾病管理至關重要。隨著獸醫護理變得越來越複雜,人們越來越期望能夠快速提供明確結果的高度可靠的診斷工具。寵物和牲畜傳染病的發生率不斷上升,增加了對此類準確診斷解決方案的需求。
伴侶動物
食品生產動物
伴侶動物佔據產業最大佔有率
報告中還根據動物類型提供了詳細的市場區隔和分析。這包括伴侶動物和食用動物。報告稱,伴侶動物佔據了最大的市場。
獸醫傳染病診斷市場中的伴侶動物細分市場是由對寵物健康和保健的關注以及診斷技術的進步所推動的。此外,寵物主人越來越重視早期疾病檢測,他們更加意識到主動健康管理的好處,正在推動市場成長。這種認知的提高導致對診斷服務的需求不斷成長,這些服務可以在疾病變得嚴重之前識別出疾病,從而為寵物帶來更好的健康結果。該細分市場也受到先進診斷工具可用性的推動,例如分子分析和快速照護端測試,這些工具可提供準確、及時的結果。這些創新使獸醫能夠更有效地診斷和治療感染,從而提高伴侶動物的整體護理品質。
細菌感染
病毒感染
寄生蟲感染
其他
細菌感染是主要的細分市場
該報告根據感染類型對市場進行了詳細的細分和分析。這包括細菌感染、病毒感染、寄生蟲感染等。根據該報告,細菌感染佔最大部分。
獸醫傳染病診斷市場的細菌感染部分是由動物細菌性疾病的快速流行所推動的,這需要先進的診斷工具來進行有效的管理和控制。寵物和牲畜中鉤端螺旋體病、結核病和沙門氏菌等細菌感染的發生率不斷上升,推動了對精確診斷解決方案的需求。人們越來越認知到細菌性疾病對動物健康和生產力的影響,這也推動了對可靠診斷方法的需求,以確保早期發現和介入。此外,該領域的發展受到食品安全焦點轉移的推動,因為牲畜的細菌感染可能導致食品供應污染,從而引發嚴格的測試和監測要求。獸醫醫療基礎設施和服務的擴展,特別是在新興經濟體,透過增加診斷技術的取得來支持該領域的成長。
參考實驗室
獸醫實驗室和診所
照護端/內部測試
科學研究院所和大學
參考實驗室主導市場
該報告提供了基於最終用戶的詳細市場細分和分析。這包括參考實驗室、獸醫實驗室和診所、照護端/內部測試以及研究機構和大學。根據該報告,參考實驗室代表了最大的部分。
獸醫傳染病診斷市場的參考實驗室部分是由診斷測試要求日益複雜性所推動的。隨著獸醫診斷變得越來越複雜,參考實驗室的先進能力和專業知識越來越受到依賴。此細分市場的推動因素是對準確、全面的診斷測試的需求不斷成長,這些測試可以區分各種病原體和疾病。這種複雜性需要使用高度專業化的設備和熟練的人員,這是參考實驗室的標誌。此外,該細分市場受益於需要徹底和高解析度分析的診斷樣本量的增加,進一步強調了對參考實驗室的需求。對分子診斷和基因組分析等先進測試方法的需求不斷成長,推動了對能夠高精度進行這些測試的專業參考實驗室的需求。
北美洲
美國
加拿大
亞太
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
北美市場領先,佔據最大的獸醫傳染病診斷市場佔有率
該報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,北美是獸醫傳染病診斷的最大區域市場。
北美獸醫傳染病診斷市場是由寵物和牲畜傳染病日益普及所推動的。該地區犬瘟熱、貓白血病和各種人畜共通感染等疾病的發生率不斷上升,凸顯了對有效診斷解決方案的需求。寵物主人對早期發現和預防疾病重要性的認知不斷提高,也推動了該區域市場的發展。北美的寵物主人對寵物的健康更加了解和主動,這刺激了對先進診斷服務的需求。此外,獸醫診斷技術的快速進步,包括分子生物學、快速檢測方法和自動分析儀的創新,正在支持市場的成長。這些進步提高了診斷過程的準確性、速度和效率。除此之外,在私營和公共部門大量投資的支持下,獸醫研究和開發(R&D)的日益關注推動了市場的發展。
市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。獸醫傳染病診斷行業的一些主要市場參與者包括 Abbott Laboratories、Biomerieux SA、Creative Diagnostics、HESKA Corporation、Innovative Diagnostics、IDEXX Laboratories Inc.、Neogen Corporation、Qiagen NV、Randox Laboratories Ltd、Thermo Fisher Scientific Inc、Viac 。 ETC。
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
市場上一些主要的獸醫傳染病診斷公司正在積極參與多項策略性舉措,以保持競爭優勢並推動市場成長。這些公司專注於廣泛的研發,以創新和增強診斷技術。透過大力投資研發,他們的目標是引入先進的診斷工具,例如分子測定和快速檢測設備,以提高檢測傳染病的準確性和速度。與研究機構和學術組織的合作也是一個優先事項,促進尖端技術和解決方案的發展。此外,這些參與者正在透過策略性收購和合作夥伴關係擴大其產品組合,使他們能夠提供更廣泛的診斷解決方案並進入新市場。他們還正在增強製造能力,以滿足對高品質診斷產品不斷成長的需求。主要參與者還採用數位技術和資料分析來改善診斷流程,並提供可提供即時結果和預測見解的整合解決方案。
2023 年,IDEXX 實驗室推出了一項開創性的獸醫診斷測試,用於檢測貓和狗的腎臟損傷。該測試是同類測試中的首次,是 IDEXX 策略的一部分,該策略旨在透過先進的診斷解決方案擴展其產品組合,以滿足獸醫護理中未滿足的需求。新測試預計將顯著改善寵物的早期診斷和治療結果,提高它們的生活品質並延長壽命。
2023 年,瑪氏收購了 HESKA Corporation,將 HESKA 整合到瑪氏寵物護理的科學與診斷部門,從而顯著拓寬了先進診斷技術的獲取範圍並加速了研發計劃。此次收購預計將增強 HESKA 為全球獸醫專業人士提供全面診斷解決方案的能力,包括現場診斷、遠距醫療和創新技術。
2024 年,Neogen Corporation 推出了 SureKill Gel Bait Pro Applicator,擴大了其產品線。 SureKill 系列的這項新產品旨在增強害蟲防治解決方案,特別是在動物健康優先的環境中。該噴藥器旨在提供高效且有效的害蟲防治,確保牲畜和寵物擁有更安全、更健康的條件。
The global veterinary infectious disease diagnostics market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Increasing disease prevalence in pets and livestock, rising pet owner awareness, surging technological advancements, the need for accurate diagnostics, adoption of advanced tools, heightened pet health concerns, expanding veterinary infrastructure, government initiatives for zoonotic disease prevention, and enhanced research funding are factors fueling the market growth.
Major Market Drivers: Globally, the rising prevalence of zoonotic diseases is significantly increasing the demand for advanced diagnostic solutions, creating a positive outlook for the market. Additionally, increasing government initiatives and funding for animal healthcare is driving the veterinary infectious disease diagnostics market growth. Moreover, the expansion of livestock industry and escalating initiatives by major players for conducting research and development (R&D) activity is propelling the market growth. Additionally, increasing utilization of point-of-care (POC) diagnostics, burgeoning telemedicine usage for veterinary care, and growing consumer awareness about animal welfare and quality standards are further boosting the veterinary infectious disease diagnostics demand.
Key Market Trends: The shifting preference toward molecular diagnostics due to their superior sensitivity and specificity is one of the primary market trends. Moreover, the surging use of clustered regularly interspaced short palindromic repeats (CRISPR) for diagnostics as it can be operated on-site is another factor facilitating the market growth. Additionally, the rising integration of artificial intelligence (AI) and machine learning (ML), especially in diagnostic tools, to produce more accurate results is fostering a positive veterinary infectious disease diagnostics market outlook. In line with this, the increasing demand for companion animals and the gradual shift towards multiplex diagnostic assays that detect a variety of pathogens at the same time are fueling the market growth. Furthermore, the collaborations between veterinary practices and diagnostic laboratories and burgeoning demand for point-of-care (POC) diagnostic solutions are driving the market forward.
Geographical Trends: As per the veterinary infectious disease diagnostics market forecast, North America leads the market due to the presence of advance healthcare infrastructure, along with growing number pet ownership and burgeoning investment in animal health. Moreover, the increasing focus on research and development (R&D) by key players and favorable government policies are supporting the regional market growth. Europe holds a considerable share in the market due to stringent animal health regulations and the presence of a number of key market players. Furthermore, in Asia Pacific, the growing awareness of animal health, the easy availability of infectious diagnostics, and burgeoning government funding in animal health are accelerating the market growth.
Competitive Landscape: Some of the major market players in the veterinary infectious disease diagnostics industry include Abbott Laboratories, Biomerieux SA, Creative Diagnostics, HESKA Corporation, Innovative Diagnostics, IDEXX Laboratories Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, and Virbac, among many others.
Challenges and Opportunities: As per the veterinary infectious disease diagnostics market report, the burgeoning cost of diagnostic tools is one of the primary factors hindering the market growth. Additionally, regulatory obstacles and complex approval processes are creating various challenges for the market players, which is another factor restraining the market growth. However, the market also offers various opportunities, such as the increasing prevalence of infectious diseases in animals and rising pet ownership are establishing a huge demand for advanced diagnostics. Moreover, rapid developments in technology, including the emergence of convenient and easy-to-use diagnostic devices and the growing concern about veterinary health and welfare are factors providing a considerable boost to the veterinary infectious disease diagnostics market revenue.
Growing Prevalence of Infectious Diseases in Pets and Livestock
Increasing prevalence of infectious diseases among pets and livestock is accelerating the market growth. For instance, feline leukemia virus (FeLV) is one of the most common infectious diseases in cats, affecting between 2-3% of felines in the US and Canada. The risk is further amplified by the surging interactions among pets and humans, which is further escalating the chances of disease transmission. Moreover, the rapid urbanization, changes in animal husbandry practices, and the rising number of diagnosed patients are supporting the market growth. Another factor boosting the veterinary infectious disease diagnostics market value is the burgeoning demand for accurate and timely diagnostics that can assist with efficient control and containment of these diseases.
Increasing Awareness Among Pet Owners
Rising awareness among pet owners about the importance of early disease detection is a crucial factor driving the market growth. With pets being considered integral family members, owners are increasingly prioritizing their health and well-being. This heightened awareness has led to a growing demand for regular health check-ups, preventive measures, and early diagnostic tests. Additionally, the availability of advanced diagnostic tools and technologies has made it easier for pet owners to access high-quality veterinary care, further driving the demand for infectious disease diagnostics.
Technological Advancements
According to the market overview, veterinary infectious disease diagnostics are witnessing considerably demand due to rapid technological advancements. Improvements in diagnostic have greatly improved the efficiency and accuracy of the results, which is further fueling the market growth. Furthermore, the introduction of molecular diagnostic technologies, such as polymerase chain reaction (PCR), designed to improve detection and identification in animal infectious diseases is facilitating the market growth. Apart from this, the incorporation of digital health tools, such as automated analyzers and telemedicine platforms, have simplified the diagnostics process, which is further supporting the market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on technology, animal type, infection type and end user.
Immunodiagnostics
Molecular Diagnostics
Others
Immunodiagnostics accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the technology. This includes immunodiagnostics, molecular diagnostics, and others. According to the report, immunodiagnostics represented the largest segment.
According to the veterinary infectious disease diagnostics market research report, the immunodiagnostics segment holds the largest market share due to the increasing demand for accurate disease detection. Immunodiagnostic tests, including enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA), are essential for their ability to specifically detect antibodies or antigens related to infectious diseases. This precision is critical in identifying pathogens and diagnosing diseases at early stages, which is crucial for effective treatment and disease management. As veterinary care becomes more sophisticated, there is a growing expectation for highly reliable diagnostic tools that can provide definitive results quickly. The escalating prevalence of infectious diseases in pets and livestock has heightened the need for such accurate diagnostic solutions.
Companion Animals
Food Producing Animals
Companion animals holds the largest share of the industry
A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animals and food producing animals. According to the report, companion animals accounted for the largest market share.
The companion animals segment in the veterinary infectious disease diagnostics market is driven by the focus on pet health and wellness, as well as advancements in diagnostic technology. Furthermore, the increasing prioritization of early disease detection by pet owners, who are more aware of the benefits of proactive health management are driving the market growth. This heightened awareness results in a growing demand for diagnostic services that can identify diseases before they become severe, leading to better health outcomes for pets. The segment is also driven by the availability of advanced diagnostic tools, such as molecular assays and rapid point-of-care tests, which offer accurate and timely results. These innovations enable veterinarians to diagnose and treat infections more effectively, enhancing the overall quality of care for companion animals.
Bacterial Infections
Viral Infections
Parasitic Infections
Others
Bacterial infections represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the infection type. This includes bacterial infections, viral infections, parasitic infections, and others. According to the report, bacterial infections represented the largest segment.
The bacterial infections segment in the veterinary infectious disease diagnostics market is driven by the burgeoning prevalence of bacterial diseases among animals, which necessitates advanced diagnostic tools for effective management and control. The rising incidence of bacterial infections such as leptospirosis, tuberculosis, and salmonella in both pets and livestock fuels demand for precise diagnostic solutions. The growing awareness of the impact of bacterial diseases on animal health and productivity also drives the need for robust diagnostic methods to ensure early detection and intervention. Additionally, the segment is driven by the shifting focus on food safety, as bacterial infections in livestock can lead to contamination of the food supply, prompting stringent testing and monitoring requirements. The expansion of veterinary healthcare infrastructure and services, particularly in emerging economies, supports the growth of this segment by enhancing access to diagnostic technologies.
Reference Laboratories
Veterinary Laboratories and Clinics
Point of Care/In House Testing
Research Institutes and Universities
Reference laboratories dominates the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes reference laboratories, veterinary laboratories and clinics, point of care/in house testing, and research institutes and universities. According to the report, reference laboratories represented the largest segment.
The reference laboratories segment in the veterinary infectious disease diagnostics market is driven by the escalating complexity of diagnostic testing requirements. As veterinary diagnostics become more sophisticated, reference laboratories are increasingly relied upon for their advanced capabilities and specialized expertise. The segment is driven by the surging need for accurate and comprehensive diagnostic tests that can differentiate between various pathogens and diseases. This complexity necessitates the use of highly specialized equipment and skilled personnel, which are hallmarks of reference laboratories. Additionally, the segment benefits from the increasing volume of diagnostic samples that require thorough and high-resolution analysis, further underscoring the need for reference laboratories. The rising demand for advanced testing methods, such as molecular diagnostics and genomic analysis, drives the need for specialized reference laboratories capable of conducting these tests with high precision.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest veterinary infectious disease diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for veterinary infectious disease diagnostics.
The North American veterinary infectious disease diagnostics market is driven by the growing prevalence of infectious diseases among pets and livestock. The rising incidence of diseases such as canine distemper, feline leukemia, and various zoonotic infections in the region underscores the need for effective diagnostic solutions. The regional market is also driven by the burgeoning awareness among pet owners about the importance of early detection and prevention of diseases. Pet owners in North America are more informed and proactive about their pets' health, which fuels demand for advanced diagnostic services. Moreover, the surging technological advancements in veterinary diagnostics, including innovations in molecular biology, rapid testing methods, and automated analyzers, are supporting the market growth. These advancements enhance the accuracy, speed, and efficiency of diagnostic processes. Apart from this, the market is driven by the escalating focus on veterinary research and development (R&D), supported by substantial investments from both private and public sectors.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the veterinary infectious disease diagnostics industry include Abbott Laboratories, Biomerieux SA, Creative Diagnostics, HESKA Corporation, Innovative Diagnostics, IDEXX Laboratories Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac., etc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Some of the key veterinary infectious disease diagnostics companies in the market are actively engaged in several strategic initiatives to maintain their competitive edge and drive market growth. These companies are focusing on extensive R&D to innovate and enhance diagnostic technologies. By investing heavily in R&D, they aim to introduce advanced diagnostic tools, such as molecular assays and rapid testing devices, that offer greater accuracy and speed in detecting infectious diseases. Collaboration with research institutions and academic organizations is also a priority, facilitating the development of cutting-edge technologies and solutions. Additionally, these players are expanding their product portfolios through strategic acquisitions and partnerships, enabling them to offer a broader range of diagnostic solutions and enter new markets. They are also enhancing their manufacturing capabilities to meet the growing demand for high-quality diagnostic products. Key players are also adopting digital technologies and data analytics to improve diagnostic processes and provide integrated solutions that offer real-time results and predictive insights.
In 2023, IDEXX Laboratories introduced a pioneering veterinary diagnostic test to detect kidney injury in cats and dogs. This test, which is the first of its kind, is part of IDEXX's strategy to expand its portfolio with advanced diagnostic solutions that address unmet needs in veterinary care. The new test is expected to significantly improve early diagnosis and treatment outcomes for pets, enhancing their quality of life and extending lifespans.
In 2023, Mars acquired HESKA Corporation to integrate HESKA into Mars Petcare's Science & Diagnostics division, significantly broadening access to advanced diagnostic technologies and accelerating research and development initiatives. This acquisition is expected to enhance HESKA's capabilities in delivering comprehensive diagnostic solutions, including point-of-care diagnostics, telemedicine, and innovative technologies for veterinary professionals globally.
In 2024, Neogen Corporation expanded its product line with the introduction of the SureKill Gel Bait Pro Applicator. This new addition to the SureKill line aims to enhance pest control solutions, particularly in environments where animal health is a priority. The applicator is designed to provide efficient and effective pest control, ensuring safer and healthier conditions for livestock and pets.